David Spencer Mangum
No Rating Available
(Learn About Our Rating System)

David Spencer Mangum, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Research North

Clinic 2D/E, BMT/Hematology
Salt Lake City
801-587-4745

University of Utah Hospital

Salt Lake City
801-662-4700

  • Dr. Mangum received his medical degree from the Albert Einstein College of Medicine (affiliated with Yeshiva University). He then completed his Pediatric residency at Primary Children´s Hospital (affiliated with the University of Utah), which was followed by a pediatric Hematology Oncology Fellowship at St Jude Children’s Research Hospital (affiliated with the University of Tennessee). Afterwards, he completed an additional two year Physician Scientist Training Program fellowship in the equivalent of an instructor role at St. Jude Children’s Research Hospital while still also continuing to care for patients. Following this, Dr. Mangum joined the faculty of Nemours Children’s Hospital in Delaware with an academic appointment as a clinical assistant professor of pediatrics at the Sidney Kimmel Medical College, where he practiced for three years. Dr. Mangum is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology Oncology. Dr. Mangum’s academic interests have focused primarily on Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia, with his clinical interests focused on patients with Leukemias, Lymphomas, and histiocytic disorders of all kinds. However, he is comfortable with caring for any patient across the entire pediatric hematology oncology spectrum.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

  • Dr. Mangum received his medical degree from the Albert Einstein College of Medicine (affiliated with Yeshiva University). He then completed his Pediatric residency at Primary Children´s Hospital (affiliated with the University of Utah), which was followed by a pediatric Hematology Oncology Fellowship at St Jude Children’s Research Hospital (affiliated with the University of Tennessee). Afterwards, he completed an additional two year Physician Scientist Training Program fellowship in the equivalent of an instructor role at St. Jude Children’s Research Hospital while still also continuing to care for patients. Following this, Dr. Mangum joined the faculty of Nemours Children’s Hospital in Delaware with an academic appointment as a clinical assistant professor of pediatrics at the Sidney Kimmel Medical College, where he practiced for three years. Dr. Mangum is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology Oncology. Dr. Mangum’s academic interests have focused primarily on Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia, with his clinical interests focused on patients with Leukemias, Lymphomas, and histiocytic disorders of all kinds. However, he is comfortable with caring for any patient across the entire pediatric hematology oncology spectrum.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Hematology/Oncology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

    Education history

    Fellowship Clinical Pediatric Hematology - Oncology - St. Jude Children's Research Hospital Fellow
    General Pediatrics - University of Utah School of Medicine Resident
    Professional Medical Medicine - Albert Einstein College of Medicine of Yeshiva University M.D.
    Biomedical Engineering - University of Utah B.S.

    Selected Publications

    Journal Article

    1. Mangum DS, Bishop JD, Zhou Y, Cheng C, Karol SE, Rubnitz JE, Ribeiro RC, Yang JJ, Mullighan CG, Jeha S, Pui CH, Inaba H (2022). Characterisation of children and adolescents with acute lymphoblastic leukaemia who presented without peripheral blood blasts at diagnosis. Br J Haematol, 200(3), 338-343. (Read full article)
    2. Davidow K, Mumanachit S, Mangum DS (2022). The two-hit hypothesis in practice: Monozygotic twins with simultaneous hyperdiploid acute lymphoblastic leukemia. Pediatr Blood Cancer, 69(10), e29885. (Read full article)
    3. Mangum DS, Meyer JA, Mason CC, Shams S, Maese LD, Gardiner JD, Downie JM, Pei D, Cheng C, Gleason A, Luo M, Pui CH, Aplenc R, Hunger SP, Loh M, Greaves M, Trede N, Raetz E, Frazer JK, Mullighan CG, Engel ME, Miles RR, Rabin KR, Schiffman JD (2022). Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. JAMA Oncol, 7(10), 1521-1528. (Read full article)
    4. Mangum DS, Downie J, Mason CC, Jahromi MS, Joshi D, Rodic V, Mschen M, Meeker N, Trede N, Frazer JK, Zhou Y, Cheng C, Jeha S, Pui CH, Willman CL, Harvey RC, Hunger SP, Yang JJ, Barnette P, Mullighan CG, Miles RR, Schiffman JD (2013). VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia. Leukemia, 28(1), 216-20. (Read full article)
    5. Mangum DS, Verma A, Weng C, Sheng X, Larsen R, Kirchhoff AC, Druzgal C, Fluchel M (2013). A comparison of central lines in pediatric oncology patients: Early removal and patient centered outcomes. Pediatr Blood Cancer, 60(11), 1890-5. (Read full article)

    Review

    1. Mangum DS, Caywood E (2022). A clinician's guide to HLA matching in allogeneic hematopoietic stem cell transplant. [Review]. Hum Immunol, 83(10), 687-694. (Read full article)

    Case Report

    1. Kube P, Parisio K, Mangum DS, Powell J (2022). Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity. BMJ Case Rep, 15(8). (Read full article)
    2. Gonzales MR, White JC, Mangum DS, Powell JL (2022). Sporadic extranodal Rosai-Dorfman-Destombes disease treated with tocilizumab. Pediatr Blood Cancer, e29754. (Read full article)
    3. Parisio K, Mangum DS, Powell J (2020). A novel and successful therapeutic approach in the treatment of a patient with simultaneous relapsed Ewing sarcoma and therapy-related acute myeloid leukemia. Pediatr Blood Cancer, 67(7), e28240. (Read full article)
    4. Ferguson-Paul K, Mangum S, Porter A, Leventaki V, Campbell P, Wolf J (2016). Hemophagocytic Lymphohistiocytosis and Progressive Disseminated Histoplasmosis. Emerg Infect Dis, 22(6), 1119-21. (Read full article)